Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ticonderoga Capital is a private equity and venture capital firm focused on growth-stage investments in the healthcare services, software, and business services sectors. Established in 1997, the firm provides expansion capital and recapitalization for companies that have reached a significant revenue milestone, typically between $5 million and $50 million. While the firm does not develop therapeutic products or maintain a drug pipeline, it is a key player in the healthcare industry through its investments in service-oriented and technology-driven healthcare companies. Ticonderoga Capital emphasizes a partnership-driven approach, working closely with management teams to scale operations and enhance market positioning. The firm is headquartered in Wellesley, Massachusetts, and primarily targets opportunities within the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ticonderoga Capital.